Abstract |
The activation of β-cell's A- and B-type gamma-aminobutyric acid receptors (GABAA-Rs and GABAB-Rs) can promote their survival and replication, and the activation of α-cell GABAA-Rs promotes their conversion into β-cells. However, GABA and the most clinically applicable GABA-R ligands may be suboptimal for the long-term treatment of diabetes due to their pharmacological properties or potential side-effects on the central nervous system (CNS). Lesogaberan ( AZD3355) is a peripherally restricted high-affinity GABAB-R-specific agonist, originally developed for the treatment of gastroesophageal reflux disease ( GERD) that appears to be safe for human use. This study tested the hypothesis that lesogaberan could be repurposed to promote human islet cell survival and β-cell replication. Treatment with lesogaberan significantly enhanced replication of human islet cells in vitro, which was abrogated by a GABAB-R antagonist. Immunohistochemical analysis of human islets that were grafted into immune-deficient mice revealed that oral treatment with lesogaberan promoted human β-cell replication and islet cell survival in vivo as effectively as GABA (which activates both GABAA-Rs and GABAB-Rs), perhaps because of its more favorable pharmacokinetics. Lesogaberan may be a promising drug candidate for clinical studies of diabetes intervention and islet transplantation.
|
Authors | Jide Tian, Hoa Dang, Angela Hu, Willem Xu, Daniel L Kaufman |
Journal | Journal of diabetes research
(J Diabetes Res)
Vol. 2017
Pg. 6403539
( 2017)
ISSN: 2314-6753 [Electronic] England |
PMID | 29018828
(Publication Type: Journal Article)
|
Chemical References |
- GABA-B Receptor Agonists
- GABA-B Receptor Antagonists
- Hypoglycemic Agents
- Phosphinic Acids
- Propylamines
- lesogaberan
|
Topics |
- Animals
- Apoptosis
(drug effects)
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Diabetes Mellitus, Experimental
(blood, drug therapy, pathology, surgery)
- Drug Repositioning
- GABA-B Receptor Agonists
(chemistry, pharmacology, therapeutic use)
- GABA-B Receptor Antagonists
(pharmacology)
- Humans
- Hypoglycemic Agents
(antagonists & inhibitors, pharmacology, therapeutic use)
- Immunohistochemistry
- Insulin-Secreting Cells
(cytology, drug effects, metabolism, pathology)
- Islets of Langerhans
(cytology, drug effects, metabolism, pathology)
- Islets of Langerhans Transplantation
- Mice, SCID
- Phosphinic Acids
(antagonists & inhibitors, pharmacology, therapeutic use)
- Propylamines
(antagonists & inhibitors, pharmacology, therapeutic use)
- Random Allocation
- Tissue Banks
- Tissue Culture Techniques
- Transplantation, Heterotopic
|